# Apherma Corporation

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/apherma

- Industry: Medical Devices & Equipment
- Headquarters: Sunnyvale, US
- Website: www.apprema.com
- Total disclosed funding: $1.5M
- Latest round: Series B (Dec 9, 2004)
- Investors on record: 1

## About

Apherma Corporation specializes in providing premium domain names tailored for web application development and online community platforms. The company facilitates ownership through sales and lease-to-own options, catering to businesses seeking a unique online identity.Founded in 2000, Apherma Corporation, headquartered in Sunnyvale, US, focuses on domain acquisition and management. The company has not undergone any significant shifts in strategy and has operated under a consistent business model since inception. There is no information regarding subsidiaries or parent companies. The company raised USD 1.5 mn in Series B funding on December 9, 2004, from Maton Venture, marking the total amount raised to USD 1.5 mn and its current valuation at USD 30.685 mn. The founder's history and other ventures are not provided.Apprema.com offers a premium domain name aimed at businesses in web application development and online social community sectors. The core service involves selling and lease-to-own options for the domain apprema.com, ensuring seamless ownership transfer through registrars like GoDaddy or NameSilo. This service is essential for startups and established companies in North America and Europe looking to enhance their online presence. Additionally, Apprema.com provides logo design files to strengthen brand identity.Apherma Corporation's revenue model is based on the sale and leasing of premium domain names, regarded as high-value digital assets. Clients can engage in direct purchases or lease-to-own agreements, which allow immediate access to domains while managing financial commitments. The inclusion of professionally designed logos adds value, promoting investment in brand identity. The pricing structure varies based on market demand, and transactions are executed transparently without hidden fees.Apherma Corporation plans to enhance its offerings by developing new products, including additional premium domain names tailored for specific niches. The company aims to expand into markets in Asia and South America by 2025. The recent Series B funding of USD 1.5 mn will support these initiatives, focusing on product development and market entry strategies. The growth strategy reflects a commitment to leveraging existing assets to explore new opportunities.

## Funding rounds

- Series B, Dec 9, 2004, $1.5M — Maton Venture

## Investors

- Maton Venture (https://capitalatlas.ai/funds/maton-venture) — Series B